Scholar Rock Holding Corporation

    Jurisdiction
    United States
    LEI
    549300Z1FLPGL4OWJ459
    ISIN
    US80706P1030 (SRRK)
    Sectors
    1. Healthcare
    2. Biotechnology

    Scores

    InsiderPie Expert Score
    51 / 100
    Even with peer group:
    49 / 100
    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    3 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    4 / 7

    Profile

    Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. Read full profile

    Fundamentals

    Net revenue
    €0.00
    Gross margin
    0.0%
    EBIT
    -€275.79M
    EBIT margin
    0.0%
    Net income
    -€269.27M
    Net margin
    0.0%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €71.22M +∞% -€270.38M +0.4%
    €238.02M +234.2% -€179.30M -33.7%
    €436.01M +83.2% -€52.78M -70.6%

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    No dividend payouts

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    Name Title Transaction Date Shares Price Value
    Parlavecchio Caryn CHRO -2.2K $31.17 -$67.89K

    Earnings Calls

    Investor transactions

    Name Shares Value Last change Change type
    Peter Brown 317K $10.20M +272K Buy

    Earnings Calls

    Latest earnings call: August 6, 2025 (Q2 2025)

    Add to watchlist

    Notifications